Micron Waste’s Subsidiary starts to Manufacture Made in Canada Face Masks pursuant to its Medical Device Establishment License

VANCOUVER, BC, Sept. 21, 2020 /CNW/ – Micron Waste Technologies Inc. (“Micron”…

Penny Stock Evofem Biosciences (EVFM) Experiences “Odd” Side Effects

Insider Selling Sends EVFM Stock Spiraling Lower On September 11th

Algernon Announces Enrollment of 50th Patient in Multinational 2b/3 Human Study of Ifenprodil for Treatment of COVID-19

VANCOUVER, British Columbia, Sept. 02, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…

Revive Therapeutics Enters into Clinical Trial Agreement to Evaluate Psilocybin for the Treatment of Methamphetamine Use Disorder

TORONTO, Sept. 02, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

Revive Therapeutics Announces IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19

TORONTO, Aug. 31, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

New Wave Holdings Corp Appoints Dr. Wade Davis to Psychedelic Research Advisory Board

TORONTO, Aug. 31, 2020 /CNW/ – NEW WAVE HOLDINGS CORP. (the “Company”…

Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19

Revive to also explore FDA Expanded Access Program (Compassionate Use) for Bucillamine in COVID-19

Revive Therapeutics to Expand Phase 3 Clinical Trial for Bucillamine in COVID-19 in Asia-Pacific and Canada

TORONTO, Aug. 19, 2020 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or…

Fandom Sports Announces Appointment of CSO and CTO

Vancouver, British Columbia–(Newsfile Corp. – August 18, 2020) – FANDOM SPORTS Media…

Algernon CEO Presents Corporate Update Featured on BioPub Webcast Hosted by Dr. KSS MD PhD

VANCOUVER, British Columbia, Aug. 17, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc.…